Cargando…
Cyclophosphamide as a first-line therapy in LGL leukemia
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017255/ https://www.ncbi.nlm.nih.gov/pubmed/24280867 http://dx.doi.org/10.1038/leu.2013.359 |
| _version_ | 1782479937426423808 |
|---|---|
| author | Moignet, A Hasanali, Z Zambello, R Pavan, L Bareau, B Tournilhac, O Roussel, M Fest, T Awwad, A Baab, K Semenzato, G Houot, R Loughran, T P Lamy, T |
| author_facet | Moignet, A Hasanali, Z Zambello, R Pavan, L Bareau, B Tournilhac, O Roussel, M Fest, T Awwad, A Baab, K Semenzato, G Houot, R Loughran, T P Lamy, T |
| author_sort | Moignet, A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4017255 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-40172552014-05-13 Cyclophosphamide as a first-line therapy in LGL leukemia Moignet, A Hasanali, Z Zambello, R Pavan, L Bareau, B Tournilhac, O Roussel, M Fest, T Awwad, A Baab, K Semenzato, G Houot, R Loughran, T P Lamy, T Leukemia Letter to the Editor Nature Publishing Group 2014-05 2013-12-20 /pmc/articles/PMC4017255/ /pubmed/24280867 http://dx.doi.org/10.1038/leu.2013.359 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Letter to the Editor Moignet, A Hasanali, Z Zambello, R Pavan, L Bareau, B Tournilhac, O Roussel, M Fest, T Awwad, A Baab, K Semenzato, G Houot, R Loughran, T P Lamy, T Cyclophosphamide as a first-line therapy in LGL leukemia |
| title | Cyclophosphamide as a first-line therapy in LGL leukemia |
| title_full | Cyclophosphamide as a first-line therapy in LGL leukemia |
| title_fullStr | Cyclophosphamide as a first-line therapy in LGL leukemia |
| title_full_unstemmed | Cyclophosphamide as a first-line therapy in LGL leukemia |
| title_short | Cyclophosphamide as a first-line therapy in LGL leukemia |
| title_sort | cyclophosphamide as a first-line therapy in lgl leukemia |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4017255/ https://www.ncbi.nlm.nih.gov/pubmed/24280867 http://dx.doi.org/10.1038/leu.2013.359 |
| work_keys_str_mv | AT moigneta cyclophosphamideasafirstlinetherapyinlglleukemia AT hasanaliz cyclophosphamideasafirstlinetherapyinlglleukemia AT zambellor cyclophosphamideasafirstlinetherapyinlglleukemia AT pavanl cyclophosphamideasafirstlinetherapyinlglleukemia AT bareaub cyclophosphamideasafirstlinetherapyinlglleukemia AT tournilhaco cyclophosphamideasafirstlinetherapyinlglleukemia AT rousselm cyclophosphamideasafirstlinetherapyinlglleukemia AT festt cyclophosphamideasafirstlinetherapyinlglleukemia AT awwada cyclophosphamideasafirstlinetherapyinlglleukemia AT baabk cyclophosphamideasafirstlinetherapyinlglleukemia AT semenzatog cyclophosphamideasafirstlinetherapyinlglleukemia AT houotr cyclophosphamideasafirstlinetherapyinlglleukemia AT loughrantp cyclophosphamideasafirstlinetherapyinlglleukemia AT lamyt cyclophosphamideasafirstlinetherapyinlglleukemia |